Cargando…

PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma

The PI3K-Akt pathway is activated in cancer by genetic or epigenetic events and efforts are under way to develop targeted therapies. PTEN tumor suppressor is the major brake of the pathway and a common target for inactivation in glioblastoma, one of the most aggressive and therapy-resistant cancers....

Descripción completa

Detalles Bibliográficos
Autores principales:	Molina, Jennifer R., Agarwal, Nitin K., Morales, Fabiana C., Hayashi, Yuho, Aldape, Kenneth D., Cote, Gilbert, Georgescu, Maria-Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208076/ https://www.ncbi.nlm.nih.gov/pubmed/21804599 http://dx.doi.org/10.1038/onc.2011.324

Ejemplares similares

PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase
por: Agarwal, Nitin Kumar, et al.
Publicado: (2014)

NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway–Driven Intestinal Neoplasia()
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2016)

PHLPP1 is a metastasis suppressor in melanoma
por: Dai, Meng, et al.
Publicado: (2018)

NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor
por: Morales, F C, et al.
Publicado: (2012)

NHERF1: molecular brake on the PI3K pathway in breast cancer
por: Georgescu, Maria-Magdalena
Publicado: (2008)

NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2015)

Roles for NHERF1 and NHERF2 on the Regulation of C3a Receptor Signaling in Human Mast Cells
por: Subramanian, Hariharan, et al.
Publicado: (2012)

Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2018)

Regulation of the tumor suppressor PTEN by SUMO
por: González-Santamaría, J, et al.
Publicado: (2012)

NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2016)

Detection of PHLPP1α/β in Human and Mouse Brain by Different Anti-PHLPP1 Antibodies
por: Jackson, Travis C., et al.
Publicado: (2015)

Emerging roles of PHLPP phosphatases in metabolism
por: Cha, Jong-Ho, et al.
Publicado: (2021)

Chondrocytic and pharmacokinetic properties of Phlpp inhibitors
por: Taylor, E.L., et al.
Publicado: (2021)

The Biological Relevance of NHERF1 Protein in Gynecological Tumors
por: Sonnessa, Margherita, et al.
Publicado: (2022)

Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)

Aberrant Expression of PHLPP1 and PHLPP2 Correlates with Poor Prognosis in Patients with Hypopharyngeal Squamous Cell Carcinoma
por: Zhou, Jieyu, et al.
Publicado: (2015)

The NHERF2 sequence adjacent and upstream of the ERM-binding domain affects NHERF2–ezrin binding and dexamethasone stimulated NHE3 activity
por: Yang, Jianbo, et al.
Publicado: (2015)

MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway
por: Xia, Xuewei, et al.
Publicado: (2015)

A Functional Dissection of PTEN N-Terminus: Implications in PTEN Subcellular Targeting and Tumor Suppressor Activity
por: Gil, Anabel, et al.
Publicado: (2015)

NHERF2 is crucial in ERM phosphorylation in pulmonary endothelial cells
por: Boratkó, Anita, et al.
Publicado: (2013)

HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
por: Lulić, Lucija, et al.
Publicado: (2023)

Emerging roles of PHLPP phosphatases in lung cancer
por: Xia, Xinhang, et al.
Publicado: (2023)

The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer
por: Li, Xin, et al.
Publicado: (2012)

PTEN: Tumor Suppressor and Metabolic Regulator
por: Chen, Chien-Yu, et al.
Publicado: (2018)

Nuclear NHERF1 expression as a prognostic marker in breast cancer
por: Paradiso, A, et al.
Publicado: (2013)

NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells
por: Tao, Tao, et al.
Publicado: (2017)

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings()
por: Centonze, Matteo, et al.
Publicado: (2018)

CFTR-NHERF2-LPA(2) Complex in the Airway and Gut Epithelia
por: Zhang, Weiqiang, et al.
Publicado: (2017)

Enhanced Neutrophil Immune Homeostasis Due to Deletion of PHLPP
por: Ran, Taojing, et al.
Publicado: (2019)

PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum
por: Xie, Keju
Publicado: (2023)

Intestinal TMEM16A control luminal chloride secretion in a NHERF1 dependent manner
por: Saha, Tultul, et al.
Publicado: (2021)

PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
por: Luongo, Francesca, et al.
Publicado: (2019)

SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells
por: Meneses-Morales, Ivan, et al.
Publicado: (2014)

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling
por: Wheeler, David S., et al.
Publicado: (2010)

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
por: Saponaro, Concetta, et al.
Publicado: (2018)

NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex
por: Bushau-Sprinkle, Adrienne, et al.
Publicado: (2020)

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
por: Schirosi, Laura, et al.
Publicado: (2019)

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
por: Sun, Yizhe, et al.
Publicado: (2021)

Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis
por: Liu, Jianyu, et al.
Publicado: (2008)

In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself
por: Breuksch, Ines, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5gcldvo2a85nt1rtc84cinumb2